SCHEMBL22305299

SCHEMBL22305299

CC(C)(C)OC(=O)NCC(=O)c1ccc(F)c(C(F)(F)F)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 2/20 0.44
TAS1R1 Q7RTX1 2/20 0.44
TAS1R2 Q8TE23 2/20 0.44
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
KCNQ3 O43525 1/20 0.41
KCNQ2 O43526 1/20 0.41
KCNE1 P15382 1/20 0.41
KCNQ1 P51787 1/20 0.41
CACNA1H O95180 1/20 0.40
CACNA1B Q00975 1/20 0.40
CACNA1C Q13936 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
VNN1 O95497 4/20 0.39
AR P10275 1/20 0.39
PTPN7 P35236 2/20 0.39
DUSP3 P51452 2/20 0.39
PPARD Q03181 1/20 0.38
PPARA Q07869 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4305734 0.88 LMNA (0.43) TAS1R3TAS1R1TAS1R2LMNAPOLB
SCHEMBL21180476 0.87 CHRNA1 (0.43) TAS1R3TAS1R1TAS1R2POLB
SCHEMBL12497673 0.83 EGFR (0.48) TAS1R3TAS1R1TAS1R2LMNAKCNQ3
SCHEMBL19655646 0.80 PTPN1 (0.49) LMNACACNA1HCACNA1BCACNA1CHDAC8
SCHEMBL5955544 0.79 PLOD2 (0.46) LMNAPOLB
SCHEMBL2063004 0.79 EPHX2 (0.57)
SCHEMBL311109 0.78 EPHX2 (0.43) TAS1R3TAS1R1TAS1R2POLB
SCHEMBL30208027 0.78 TAS1R3 (0.48) TAS1R3TAS1R1TAS1R2KCNQ3KCNQ2
SCHEMBL8558279 0.77 CA12 (0.46) POLB
SCHEMBL14830379 0.76 ALDH1A1 (0.52) LMNAPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020157194-A1 1,2,4-TRIAZIN-3(2H)-ONE COMPOUNDS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES BAYER AKTIENGESELLSCHAFT (DE) 2020-08-06 WO disclosed